August 14, 2007 – GlobalMedTek recently announced a revision of its Version 1.0 for its Medical Software Directory Database, providing free software in specialty, application and technology categories and giving access to over 500 vendors in an excess of 2,000 programs.

August 14, 2007 - Baseline serum complement component C4 is among independent predictors of stroke in patients with known or suspected coronary artery disease.

August 14, 2007 - High-speed dual-source computed tomography (DSCT) angiography was 95 percent sensitive and 95 percent specific in detecting significant coronary lesion, on a segment-by-segment analysis, according to the report published in the August 21 issue of the Journal of the American College of Cardiology.

August 14, 2007 - ELA Medical Inc., a Sorin Group company that specializes in the design and manufacture of implantable pacemakers and defibrillators, announced the first U.S. implant in NATURE, an observational study that will enroll 1,440 patients in North America and Europe to observe the evolution of atrio-ventricular conduction disorders in pacemaker patients over a 2-year time period.

August 13, 2007 – A study published in the Journal of the American College of Cardiology showed that when AngioJet thrombectomy is used to remove large thrombus before placement of a drug-eluting stent (DES), it is associated with significantly lower rates of subsequent death, repeat heart attack and stent thrombosis.

Aug 13, 2007 - Medtronic Inc. has entered into a definitive agreement with Biophan Technologies Inc. to acquire its MRI safety patents in a transaction worth $11 million in cash, as part of Medtronic’s strategy to develop solutions for the contraindication between pacemakers and MRI machines.

Under the terms of the agreement, Biophan will transfer to Medtronic its MRI safety patent portfolio, which includes technologies that make medical devices, such as pacemakers, safe for use with MRI.

Aug. 9, 2007 - Abiomed Inc. today announced financial results for its first quarter of fiscal 2008 with record revenue of $14.1 million, representing growth of 8 percent over a strong first quarter of fiscal 2007, which was up 55 percent over the first quarter of fiscal 2006.

Recent financial and operating highlights include:

- Record revenue of $14.1 million, which represents the highest quarterly revenue in Company history.

- Record total Impella revenue, up 157 percent and record Impella Console revenue.

August 9, 2007 - Compared with their counterparts a decade ago, today's heart attack patients are receiving emergency angioplasty or clot-busting drugs to re-open clogged arteries at a far greater rate, but 10 percent of patients who could benefit from this life-saving treatment still do not receive it, according to a study published in The American Journal of Medicine by Yale and University of Mi

August 8, 2007 - Orbotech Ltd. announced that it has signed a definitive agreement to acquire 3D - Danish Diagnostic Development A/S (DDD), a privately-held Danish company that develops and manufactures gamma cameras for nuclear medicine, as part of a strategy to generate a projected $30 million in annual revenues, which is expected to be immediately accretive to Orbotech on a non-GAAP basis.

August 8, 2007 - A U.S. District Court judge enforced a settlement this week between Abbott Laboratories Inc. and Israeli company Medinol Ltd. to removed an entanglement for a key drug-eludting stent heart device Abbott is bringing to the United States.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now